Please login to the form below

Antiretroviral therapy

This page shows the latest Antiretroviral therapy news and features for those working in and with pharma, biotech and healthcare.

NHS England will make PrEP for HIV available in April

The PrEP Impact Trial is using Mylan's generic version of Gilead Sciences’ antiretroviral therapy Truvada (emtricitabine/tenofovir disoproxil) but is due to come to an end in October.

Latest news

Gilead drug reduces HIV viral reservoir, says researcher

suppression prior to starting antiretroviral therapy (ART). ... Stem cell transplants are high-risk procedures, so the treatment wouldn’t be suitable as a routine therapy for HIV-positive people.
FDA rejects ViiV’s long-acting monthly HIV injection

ATLAS involved pateints who had been previously treated with long-acting antiretroviral therapy (ART), and showed that the combination injection matched standard therapy on viral suppression rates. ... Three patients treated with ViiV’s injectable (1%)
Dovato approval key for Glaxo in HIV treatment

ViiV already have another two-in-one STR, Juluca (dolutegravir/rilpivirine), but this is only approved for HIV patients who have achieved viral suppression with another antiretroviral therapy. ... The HIV therapy market is also likely to be affected by
GSK, J&J say monthly injection keeps HIV controlled

The long-acting antiretroviral therapy (ART) could mean that more patients adhere to the treatment regimen needed to suppress HIV, and avoid the risk of skipped doses that can help viral ... If approved, this two-drug regimen would give people living
GSK’s says depot HIV injection works over three years

Moreover, patients in a control arm receiving standard oral antiretroviral therapy (ART) who elected to swap over to the injectable regimen after 96 weeks did so without loss of viral suppression, ... combinations GSK is hoping will simplify HIV therapy

More from news
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest Intelligence

Choices, choices: the rapidly evolving HIV treatment landscape

This type of combination therapy is known as highly active antiretroviral therapy (HAART), and remains the recommended treatment for HIV today. ... Ipsos' HIV Therapy Monitor data shows that the top reason for prescribing an STR is convenience.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

WHITE PAPER: Patient nonadherence – the $637bn paradox

low level of education. culture. lay beliefs. THERAPY-RELATED FACTORS. complexity of regimen. ... How well do. clinicians estimate patients’ adherence to combination antiretroviral therapy?
What about me? Human centricity rather than patient centricity…

While the advances in antiretroviral therapy (ART) have transformed the prognosis for a whole patient cohort, the role and sense of self of HIV specialists has undeniably changed, which in turn
Marketing strategy in complex environments

Whilst not new, this approach is becoming increasingly effective for certain therapy areas, particularly oncology. ... Another popular combination therapy is HAART: Highly Active Antiretroviral Therapy used for HIV where six major types of drugs

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Planner: Salary TBC

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Senior Medical Writer, Rare diseases, Medical Communications age...: Highly competitive salary

Group Account Director, Patient Engagement & Solutions, Lond...: Highly competitive salary

Publications Director: Competitive Salary

FREELANCE (Outside IR35) Opportunities for this week below!!!: Superb Day Rate

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Account Director, Publications, Opthalmology, Medical Communicat...: Highly competitive salary

Client Services Director, Patient Engagement & Solutions, Lo...: Highly competitive salary

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Senior Account Director, Publications, Women’s health, Medical C...: Highly competitive salary

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Senior Account Manager: Salary TBC

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Medical Writer, Women’s health, Medical Communications agency, h...: Highly competitive salary

Senior Account Director, Publications, Opthalmology, Medical Com...: Highly competitive salary

PMHub

Add my company

Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

How early-stage clinical research is facilitating the new wave of personalised medicines: By Jorg Taubel...
Patient diversity in clinical trials needs to be centre stage: By Danny Buckland...
Why empathy in digital patient recruitment is vital: This is where empathy mapping can be incredibly effective....

Email:
Password:

Please login to the form below

Antiretroviral therapy

COVID-19 Updates and Daily News

Featured jobs

Quick links